MD
Pediatrix Medica (MD)
NYSE
$23.86+$0.34 (+1.45%)
Price as of Jun 23, 2026 4:10 PM EDT
  • $1.9B
    Market Cap
  • 75.92%
    1-Year Change
  • Medical Care Facilities
    Industry

Key Performance

More
  • Earnings Score: 51
  • Momentum Score: 72
  • True Yield: N/A
  • Financial Health Score: 89
TradeSmith Loading

Latest Research & News

ARS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights for neffy® (epinephrine nasal spray)

ARS Pharmaceuticals reported $32.5 million in revenue for Q3 2025, primarily from neffy epinephrine nasal spray sales. The company continues to expand market presence through direct-to-consumer campaigns and has strong cash reserves of $288.2 million.

11/10/2025, 6:00 AM • GlobeNewswire

Pediatrix (MD) Q2 EPS Jumps 56%

Pediatrix Medical Group reported strong Q2 2025 earnings, with non-GAAP EPS of $0.53 beating analyst expectations. Despite a 7.4% revenue decline due to practice divestitures, the company showed growth in hospital-based neonatal services and raised its adjusted EBITDA guidance.

08/05/2025, 4:17 PM • The Motley Fool

Peers

Statistics

More
Day Range
$23.44
$24.11
$23.52
1-Year Range
$11.98
$24.65
$23.52
Latest Close$23.52
Change
-$0.09 (-0.38%)
Volume927,029
Market Cap$1.9B
Shares Outstanding82.1M
P/E (TTM)11.43
Diluted EPS (TTM)$2.06
Enterprise Value$2.3B

Information as of 06/22/2026

Company Profile

PEDIATRIX MEDICAL GROUP INC
PEDIATRIX MEDICAL GROUP INC
https://www.pediatrix.com
$1.9B
Market Cap
$174.2M
Net Income
Sector: Healthcare
Industry: Medical Care Facilities
1301 Concord Terrace, Sunrise, FL, United States, 33323
954 384 0175

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Key Executives

  • Mark S. Ordan
  • D. Gregory Neeb
  • Mary Ann E. Moore
  • Kasandra H. Rossi
  • John C. Pepia

Current Ownership Distribution

  • Institutions1.5B (60.27%)
  • Mutual Funds1.0B (39.54%)
  • Insiders4.7M (0.19%)
  • Other0 (0.00%)